Looks like someone is getting some Lucky Socks!

Congratulations, You should receive your package soon!
Until then, share some Lucky Socks love with your friends – you could win even more!

[facebook-page href="https://facebook.com/kindredbio" width="485" height="400" tabs="timeline" show_cta="false" small_header="false" align="left" hide_cover="false" show_facepile="true"]

News

  • Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsMarch 24, 2020 - 8:33 am
  • Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial ResultsMarch 16, 2020 - 4:03 pm
  • Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:04 pm

Events

  • Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:05 pm
  • Event: Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitFebruary 18, 2020 - 8:38 am
  • Event: Kindred Biosciences to Present at Stifel Healthcare ConferenceNovember 14, 2019 - 4:11 pm
$3.98 Stock is No Change 0.00 (0.00%)
KIN (Common Stock)
Previous Close Volume
$3.98 0
Intraday High Intraday Low
$4.31 $3.95
52 Week High 52 Week Low
$11.93 $3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top